Dr Reddy's hits all-time high ahead of Jan-March earnings
Shares in Dr Reddy's Laboratories gained as much as 2.9 percent to an all-time high of Rs 2,152 on hopes the Indian drugmaker will beat earnings estimates for the March quarter by a wide margin, according to multiple dealers.

Shares in Dr Reddy's Laboratories gained as much as 2.9 percent to an all-time high of Rs 2,152 on hopes the Indian drugmaker will beat earnings estimates for the March quarter by a wide margin, according to multiple dealers.
They cite market speculations that Dr.Reddy's will report a net profit of over Rs 500 crore for the January-March period versus analyst estimates of Rs 446 crore as provided by Thomson Reuters StarMine.

They cite market speculations that Dr.Reddy's will report a net profit of over Rs 500 crore. Reuters[/caption]
Dr Reddy's shares up 0.54 percent at 1:34 p.m.
The company spokesman refrained from comment.
Reuters

BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents
Eight Russian judokas barred from world championships after Ukraine boycott
Old video of Donald Trump listening to Taylor Swift’s ‘Blank Space’ takes over internet; watch
SA20: Ex-New Zealand all-rounder Jacob Oram appointed MI Cape Town bowling coach
FIFA World Cup: Morgan Freeman, Jung Kook headline day one before Ecuador defeats hosts Qatar
